Skip to main content
OpenTrials

Clinical trial condition

Monoclonal Gammopathy of Undetermined Significance

Explore clinical trials studying Monoclonal Gammopathy of Undetermined Significance. Study availability and eligibility vary by location and protocol.

82 public trials 19 recruiting studies
Refine in advanced search Browse all conditions

Monoclonal Gammopathy of Undetermined Significance trial results

Completed

Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain

NCT00666211

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +108 more
Locations
  • Jennie Stuart Medical Center Hopkinsville, Kentucky, United States
  • Mitchell Memorial Cancer Center at Owensboro Medical Health System Owensboro, Kentucky, United States
  • Erlanger Health System Chattanooga, Tennessee, United States
  • Tennessee Plateau Oncology Crossville, Tennessee, United States
View Trial Details
Completed

Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer

NCT00002504

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Bloomington Hospital Bloomington, Indiana, United States
  • St. Vincent Hospital and Health Care Center Research Department Indianapolis, Indiana, United States
  • Bergan Mercy Medical Center Omaha, Nebraska, United States
View Trial Details

Related conditions